Stocks That Hit 52-Week Lows On Friday
During Friday's session, 132 stocks hit new 52-week lows.
Innoviva: Q2 Earnings Insights
Innoviva (NASDAQ:INVA) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Innoviva missed estimated earnings by 84.85%, reporting an EPS of $0.05 versus an estimate of $0.33.
Goldman Sachs Initiates Coverage On Innoviva with Neutral Rating, Announces Price Target of $16
Goldman Sachs analyst Chris Shibutani initiates coverage on Innoviva (NASDAQ:INVA) with a Neutral rating and announces Price Target of $16.
Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests
Theravance Biopharma, Inc. (NASDAQ:TBPH) has agreed to sell all of its units in Theravance Respiratory Company, LLC, representing 85% economic…
Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal
Innoviva Inc (NASDAQ:INVA) has agreed to acquire La Jolla Pharmaceutical Company (NASDAQ:LJPC) for $5.95 per share, representing a premium of approximately 70%…